[HTML][HTML] The Role of the Airway and Gut Microbiome in the Development of Chronic Lung Disease of Prematurity

L Boel, DJ Gallacher, JR Marchesi, S Kotecha - Pathogens, 2024 - mdpi.com
Chronic lung disease (CLD) of prematurity, a common cause of morbidity and mortality in
preterm-born infants, has a multifactorial aetiology. This review summarizes the current …

[HTML][HTML] First-year outcomes of very low birth weight preterm singleton infants with hypoxemic respiratory failure treated with milrinone and inhaled nitric oxide (iNO) …

YT Chang, JR Liu, WM Chen, CN Tseng, LC See - Plos one, 2024 - journals.plos.org
Background Inhaled nitric oxide (iNO) has a beneficial effect on hypoxemic respiratory
failure. The increased use of concurrent iNO and milrinone was observed. We aimed to …

[HTML][HTML] Impact of severity and age with variable definitions of bronchopulmonary dysplasia on neurodevelopmental outcomes

J Donlon, V Bhat, K Hunter, A Kushnir, V Bhandari - Pediatric Research, 2024 - nature.com
Background Bronchopulmonary dysplasia (BPD) is associated with neurodevelopmental
impairment (NDI). Methods To compare the ability of NICHD 2001 and Jensen 2019 …

Mitochondrial DNA mutations in extremely preterm infants with bronchopulmonary dysplasia

J Jeong, Y Lee, J Han, E Kang, D Kim, K Kim, EAR Kim… - Gene, 2024 - Elsevier
Abstract Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease affecting
extremely preterm infants. While mitochondrial dysfunction has been investigated in various …

[HTML][HTML] Assessing the agreement of chronic lung disease of prematurity diagnosis between radiologists and clinical criteria

JM Rich, LJ Lin, JL Le, JRC Abe, A Sura - Maternal Health, Neonatology …, 2024 - Springer
Background Chronic lung disease of prematurity (CLD) is the most prevalent complication of
preterm birth and indicates an increased likelihood of long-term pulmonary complications …

[HTML][HTML] Prevalence, Severity Patterns and Risk Factors of Bronchopulmonary Dysplasia in Preterm Infants Younger than 32 Weeks of Gestation in a Tertiary Centre in …

H Al Mandhari, A Khan, A Al Saadi… - Sultan Qaboos …, 2024 - ncbi.nlm.nih.gov
Objectives This study aimed to determine the rate and severity patterns of
bronchopulmonary dysplasia (BPD) and identify antenatal and postnatal factors associated …

Urinary acetaminophen metabolites and clinical outcomes in premature infants

MA Guardado, D Torgerson, C Chapin, A Atum… - medRxiv, 2024 - medrxiv.org
BACKGROUND: Extremely premature infants are treated with acetaminophen (APAP) for
discomfort and patent ductus arteriosus. A recent study found an association between APAP …

[HTML][HTML] Incidence and Predictors of Bronchopulmonary Dysplasia Development and Severity Among Preterm Infants Born at 32 Weeks of Gestation or Less

A Abushahin, SG Hamad, A Sabouni, S Alomar… - Cureus, 2024 - ncbi.nlm.nih.gov
Background As the most common chronic lung disease (CLD) related to premature birth,
bronchopulmonary dysplasia (BPD) is associated with long-term lung disease along with …

[HTML][HTML] Recent Advances in Bronchopulmonary Dysplasia Protection and Therapy

P Xia, H Li, Z Xu, Y Lu - Health, 2024 - scirp.org
For preterm infants, bronchopulmonary dysplasia (BPD) is usually caused by abnormal lung
development due to various factors during prenatal and postnatal process. One of the …

[PDF][PDF] Short-Term Results of Preterm Infants and Comparison with the Recent International Network: Obtained from a Level III Neonatal Intensive Care Unit in Türkiye

A Yılmaz, N Kaya, E Ulu, K Sak, Y Perk, M Vural - culture, 2024 - cerrahpasamedj.org
Objective: This study aimed to evaluate the effects of developments in neonatal units over
time by comparing the results of the last 15 years of our unit with recent reliable international …